Any material, compound, mixture, or preparation is included in Schedule III which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:
             (1)      Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically listed in other schedules;
             (2)      Chloral betaine;
             (3)      Chloral hydrate;
             (4)      Chlorhexadol;
             (5)      Lysergic acid;
             (6)      Lysergic acid amide;
             (7)      Methyprylon;
             (8)      Sulfondiethylmethane;
             (9)      Sulfonethylmethane;
             (10)      Sulfonmethane;
             (11)      Amobarbital, pentobarbital, and secobarbital in suppository dosage form;
             (12)      Gamma hydroxy butyrate;
             (13)      Dronabinol;
             (14)      Buprenorphine;
             (15)      Embutramide;
             (16)      Perampanel [2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl) benzonitrile], including its salts, isomers, and salts of isomers.

Source: SL 1970, ch 229, § 8 (c) (1); SDCL Supp, § 39-17-63; SL 1973, ch 260; SL 1979, ch 238, § 2; SL 1980, ch 240, § 1; SL 1992, ch 245, § 2; SL 1993, ch 247, § 4; SL 1999, ch 174, § 1; SL 2000, ch 170, § 2; SL 2003, ch 183, § 3; SL 2007, ch 194, § 2, eff. Feb. 1, 2007; SL 2014, ch 165, § 2, eff. Feb. 10, 2014.